Details for New Drug Application (NDA): 050672
✉ Email this page to a colleague
NDA 050672 describes CEFTIN, which is a drug marketed by Glaxosmithkline and is included in two NDAs. Additional details are available on the CEFTIN profile page.
The generic ingredient in CEFTIN is cefuroxime axetil. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
The generic ingredient in CEFTIN is cefuroxime axetil. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
Summary for 050672
| Tradename: | CEFTIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | cefuroxime axetil |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 125MG BASE/5ML | ||||
| Approval Date: | Jun 30, 1994 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 250MG BASE/5ML | ||||
| Approval Date: | Apr 29, 1997 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
